Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Southern Energy Corp. Completes US$23.5 Million Financings and Royalty Sale (click to learn more) Cariboo Gold History Inspires Modern Discovery (CSE:GCC) (OTC:GCCFF) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Neurocrine Biosciences Inc NBIX

Healthcare Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NBIX)

Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience and Endocrinology

PR Newswire December 16, 2025

Neurocrine Biosciences to Host R&D Day on December 16

PR Newswire December 9, 2025

Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA® (valbenazine) Capsules

PR Newswire November 20, 2025

Neurocrine Biosciences to Present at Upcoming Investor Conferences

PR Newswire November 11, 2025

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder

PR Newswire November 10, 2025

Neurocrine Biosciences Reports Third Quarter 2025 Financial Results

PR Newswire October 28, 2025

Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg Capsules

PR Newswire October 17, 2025

Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results

PR Newswire October 7, 2025

Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise

PR Newswire October 6, 2025
View More News ››

Opinion & Analysis (NDAQ:NBIX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NBIX)

Neurocrine Biosciences (NASDAQ:NBIX) Poised for Continued Gr

http://beyondspx.com/2024/08/01/neurocrine-biosciences-nasdaqnbix-poised-for-continued-growth-as-pipeline-advances-and-commercial...
MikeTester - August 2, 2024

And Soros Buys In?

http://www.gurufocus.com/StockBuy.php?symbol=NBIX
scissors14 - June 29, 2006

Pfizer Rejects Indiplon

U.S. Equity News: AstraZeneca Cholesterol Drug Effective and Abbott Phase III Data Jun 26, 2006 (M2 PRESSWIRE via COMTEX News Network...
scissors14 - June 29, 2006

Clinical trails show

San Diego-based Neurocrine Biosciences (NASDAQ: NBIX) says clinical trials show its new drug can reduce the size of inoperable advanced...
SCCNewsServices - April 19, 2000
View more Bullboard ››

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc. engages in the acquisition, exploration, and development of mineral properties in North ...
View More »

Podcasts